CELLSPRESSO Trademark

Trademark Overview


On Monday, July 24, 2017, a trademark application was filed for CELLSPRESSO with the United States Patent and Trademark Office. The USPTO has given the CELLSPRESSO trademark a serial number of 79223494. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 11, 2025. This trademark is owned by Cell Therapy Limited. The CELLSPRESSO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; veterinary pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue regenerative pharmaceutical preparations; cellular medicines, namely, stem cells for medi...

Medical and veterinary devices, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; disposable cartridges for medical and veterinary devices, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; portable medical and veterinary apparatus, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; surgical, medical, and veterinary apparatus, devices, and instruments for use in implanting regenerative cells into humans and animals to treat damaged and diseased skin, tissue, organs and body parts; surgical, medical, and veterinary apparatus, devices, and instruments for use in cell therapy and regenerative medicine...
cellspresso

General Information


Serial Number79223494
Word MarkCELLSPRESSO
Filing DateMonday, July 24, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 11, 2025
Registration Number5634962
Registration DateTuesday, December 25, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; veterinary pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue regenerative pharmaceutical preparations; cellular medicines, namely, stem cells for medical or veterinary use; reagents for medical or veterinary use; clinical medical and veterinary reagents; medical and veterinary diagnostic reagents; reagents for medical and veterinary diagnosis and medical and veterinary diagnostic research; chemical reagents for testing aqueous solutions for medical and veterinary purposes; reagents for use in biological processing for medical and veterinary purposes; media for biological and bacteriological cultures for medical and veterinary use; non-aqueous solvents for use in tests for medical and veterinary purposes; aqueous solutions for use in tests for medical and veterinary purposes; non-aqueous culture media for medical and veterinary use; chemicals preparations, namely, buffer solutions for use in tests for medical and veterinary purposes; chemicals, namely, surfactants for use in tests for medical and veterinary purposes
Goods and ServicesMedical and veterinary devices, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; disposable cartridges for medical and veterinary devices, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; portable medical and veterinary apparatus, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; surgical, medical, and veterinary apparatus, devices, and instruments for use in implanting regenerative cells into humans and animals to treat damaged and diseased skin, tissue, organs and body parts; surgical, medical, and veterinary apparatus, devices, and instruments for use in cell therapy and regenerative medicine; medical and veterinary devices, namely, applicators to implant regenerative cells into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; sample preparation devices for medical diagnostic use; apparatus for the regeneration of stem cells for medical purposes; component parts and fittings for all of the aforesaid

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateSaturday, July 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateSaturday, July 12, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCell Therapy Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameCell Therapy Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameCell Therapy Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, December 21, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 26, 2017ASSIGNED TO EXAMINER
Saturday, December 30, 2017APPLICATION FILING RECEIPT MAILED
Thursday, January 18, 2018NON-FINAL ACTION WRITTEN
Friday, January 19, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 26, 2018REFUSAL PROCESSED BY MPU
Friday, January 26, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 16, 2018REFUSAL PROCESSED BY IB
Monday, June 18, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 3, 2018EXAMINERS AMENDMENT E-MAILED
Friday, August 3, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 3, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, August 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 19, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 19, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, August 3, 2018EXAMINERS AMENDMENT -WRITTEN
Saturday, October 6, 2018NOTIFICATION PROCESSED BY IB
Tuesday, October 9, 2018PUBLISHED FOR OPPOSITION
Tuesday, October 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 25, 2018REGISTERED-PRINCIPAL REGISTER
Monday, March 25, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 5, 2019FINAL DISPOSITION PROCESSED
Friday, April 5, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 25, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 26, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 25, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 11, 2025CANCELLED SECTION 71
Saturday, December 4, 2021NEW REPRESENTATIVE AT IB RECEIVED